Key Takeaways Solventum (SOLV) posted a strong Q1 FY25 with 4.3% organic growth and raised full-year revenue guidance. SOLV's growth is driven by improved commercial focus and product innovation in MedSurg, Dental, and HIS. Tariff risks loom, but SOLV's strategic mitigations to support sustained profitability.Solventum Corporation (SOLV) delivered a robust first-quarter performance, reflecting the company’s progress on its multi-phase transformation and renewed commercial focus. The company reported earni ...

Solventum (SOLV) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Company Participants Amy Wakeham - Senior Vice President of Investor Relations & External Finance CommunicationsBryan Hanson - CEOWayde McMillan - Chief Financial OfficerPatrick Wood - Managing DirectorDavid Roman - Managing DirectorTravis Steed - Managing Director - Equity Research Conference Call Participants Rick Wise - AnalystJason Bednar - Senior Research AnalystNone - AnalystSteven Valiquette - MD & Senior Equity Research Analyst - Coveri ...

Solventum (SOLV) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Speaker0 Good afternoon. My name is Amy, and I will be your conference call operator for today. I would like to welcome everyone to the Solventum First Quarter twenty twenty five Earnings Call. As a reminder, this call is being recorded and all lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. Thank you. I would now like to turn the program over to your host ...